Interações medicamentosas
Deferasirox + Metformin-repaglinide
Gravidade: Grave
Deferasirox and Metformin-repaglinide: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Deferasirox inhibits CYP2C8 and can substantially raise repaglinide exposure, which increases the risk of hypoglycemia. Repaglinide is a sensitive CYP2C8 substrate, and the combination has been studied pharmacokinetically.
O que esta interação significa em palavras simples
Deferasirox and Metformin-repaglinide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Deferasirox belongs to Miscellaneous; Metformin-repaglinide belongs to Endocrine.
Por que acontece
Inhibition of CYP2C8 (and to a lesser extent CYP3A4) metabolism of repaglinide.
O que fazer
Avoid the combination if possible; otherwise reduce the repaglinide dose and monitor blood glucose closely.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Deferasirox e Metformin-repaglinide, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Metformin-repaglinide
Outras interações de Deferasirox
Perguntas frequentes
Can I take Deferasirox with Metformin-repaglinide?
MediHelp rates the interaction as major. Deferasirox and Metformin-repaglinide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferasirox inhibits CYP2C8 and can substantially raise repaglinide exposure, which increases the risk of hypoglycemia. Repaglinide is a sensitive CYP2C8 substrate, and the combination has been studied pharmacokinetically.
How serious is the interaction between Deferasirox and Metformin-repaglinide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible; otherwise reduce the repaglinide dose and monitor blood glucose closely.
What other medicines interact with Metformin-repaglinide?
MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
